Blog
RSS FeedPosted by Michael Wonder on 01 Feb 2017
Pharmaceutical patent challenges: company strategies and litigation outcomes
31 January 2017 - The pharmaceutical industry has experienced a large number of patent challenges in recent years. ...
Posted by Michael Wonder on 01 Feb 2017
Trump wants to blow up the FDA. The drug industry? Not so much
1 February 2017 - President Donald Trump wants to remake the FDA. ...
Posted by Michael Wonder on 01 Feb 2017
Can a butterfly cause a typhoon? Just ask Innate Immunotherapeutics
1 February 2017 - Can the flutter of a butterfly in South America, or in this case Oceania, really cause ...
Posted by Michael Wonder on 31 Jan 2017
Trump pushes drug makers for lower prices, more U.S. production
31 January 2017 - U.S. President Donald Trump on Tuesday met with top executives from some of the biggest drug ...
Posted by Michael Wonder on 30 Jan 2017
Big drug companies should secede from the Pharmaceutical Research And Manufacturers Of America
27 January 2017 - When Martin Shkreli, then the CEO of Turing Pharmaceuticals, infamously raised the price of the rare ...
Posted by Michael Wonder on 24 Jan 2017
America’s biopharmaceutical companies launch groundbreaking, multi-year initiative heralding new era of medicine
23 January 2017 - Advertising and public affairs campaign will convene national health care dialogue, educational events and stakeholder engagements across ...
Posted by Michael Wonder on 19 Jan 2017
Statement from FDA Commissioner announcing FDA Oncology Center of Excellence launch
19 January 2017 - Today the U.S. FDA is establishing the Oncology Center of Excellence (OCE) and appointing Dr. Richard ...
Posted by Michael Wonder on 19 Jan 2017
Six month market exclusivity extensions to promote research offer substantial returns for many drug makers
18 January 2017 - To incentivise pharmaceutical manufacturers to invest in areas of unmet medical need, policy makers frequently propose extending ...
Posted by Michael Wonder on 17 Jan 2017
Drug makers manipulate orphan drug rules to create prized monopolies
17 January 2017 - More than 30 years ago, Congress overwhelmingly passed a landmark health bill aimed at motivating pharmaceutical ...
Posted by Michael Wonder on 12 Jan 2017
What Trump gets wrong about drug companies
12 January 2017 - President-elect Donald Trump was hardly timid in declaring Wednesday that drug companies are “getting away with ...
Posted by Michael Wonder on 12 Jan 2017
Biopharma needs to stop getting blindsided by Donald Trump
11 January 2017 - The day after Donald Trump won the US presidential election, pharma and biotech investors seemed to ...
Posted by Michael Wonder on 11 Jan 2017
National Cancer Institute and drug companies aim to speed up clinical trials
11 January 2017 - The National Cancer Institute launched an effort Wednesday to speed up clinical trials by getting researchers ...
Posted by Michael Wonder on 08 Jan 2017
Don’t thank big government for medical breakthroughs
5 January 2017 - New cures come from private research, not cash dumped into the National Institutes of Health. ...
Posted by Michael Wonder on 05 Jan 2017
New “21st Century Cures” legislation: speed and ease versus science
5 January 2017 - The 21st Century Cures Act was signed into law in December 2016. Praised by its advocates as ...
Posted by Michael Wonder on 04 Jan 2017
The changing face of clinical trials: the large pharmaceutical company perspective
4 January 2017 - Large pharmaceutical companies conduct clinical trials to evaluate efficacy and identify safety issues for candidate drugs as ...